Recurrent Malignant Melanoma Detected on 18F-Fluciclovine PET/CT Imaging for Prostate Cancer. (October 2017)

• Record Type: Journal Article
• Authors: Teoh, Eugene J.; Tsakok, Maria T.; Bradley, Kevin M.; Hyde, Katherine; Subesinghe, Manil; Gleeson, Fergus V.
• Is Part Of: Clinical nuclear medicine. Volume 42:Number 10(2017)
• Publication Date: 2017-10
• Subjects: FACBC -- fluciclovine -- melanoma -- PET; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000001789
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract : Abstract: A 66-year-old man presented with biochemical recurrence of prostate cancer and underwent 18 F-fluciclovine PET/CT to detect sites of recurrence. He had a history of resected truncal stage IIIC malignant melanoma, with bilateral axillary node involvement on sentinel node biopsy, in complete remission for 3 years. 18 F-fluciclovine PET/CT demonstrated an incidental fluciclovine-avid right axillary node (SUVmax = 4.3). Diagnostic sampling confirmed recurrent malignant melanoma.